학술논문

Design of vesicles of 1,2-di-O-acyl-3-O-(β-d-sulfoquinovosyl)-glyceride bearing two stearic acids (β-SQDG-C18), a novel immunosuppressive drug
Document Type
Article
Source
Biochemical Pharmacology. Dec2004, Vol. 68 Issue 12, p2379-2386. 8p.
Subject
*IMMUNOSUPPRESSIVE agents
*TEMPERATURE measurements
*LEUCOCYTES
*FATTY acids
Language
ISSN
0006-2952
Abstract
Abstract: The immunosuppressive effects of synthetic sulfo-glycolipids in the class of sulfoquinovosyl-diacylglycerols (SQDG), including stereoisomers, were interesting in development of a promising clinical drug. Especially, 1,2-di-O-stearoyl-3-O-(6-deoxy-6-sulfo-β-d-glucopyranosyl)-sn-glycerol (β-SQDG-C18) was thought to be a valuable candidate because of the preliminary observations of its high inhibitory activities in spite of low toxicities. The problem of using this material is to find an applicable way avoiding its low solubility in water. The vesicle formation of β-SQDG-C18 is advantageous to i.v. administration in its chemico-structural character. With preparation in water, β-SQDG-C18 was hard to form vesicles, because its hydrophilicity was strong. We examined the suitable parameter of the vesicle forming condition. It was possible to take a balance between the hydrophilicity and the hydrophobicity of the β-SQDG-C18 molecule to be optimized to form vesicles in 150mM PBS. In addition, we demonstrated the strong immunosuppressive activity of β-SQDG-C18 vesicles. This is the first report of the preparation method of β-SQDG-C18 vesicles, which should facilitate in vitro and in vivo application. [Copyright &y& Elsevier]